Sale of Securities

HALOZYME THERAPEUTICS, INC. Filed 2024-10-15 Acc 0001950047-24-007745

Documents 1

2024-10-17 SC 13G Amended Statement of Ownership
2024-10-16 144 Sale of Securities
2024-10-16 4 SVP, CHIEF TECHNICAL OFFICER sold 20,000 shares at an average $53.50 ($1,070,059)
2024-10-15 144 Sale of Securities
2024-10-09 144 Sale of Securities
2024-10-09 4 PRESIDENT AND CEO sold 20,000 shares at an average $53.29 ($1,065,743)
2024-10-08 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…